Choriogonadotropin Alfa News
Choriogonadotropin Alfa currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Choriogonadotropin Alfa with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Ovitrelle is indicated in the treatment of: women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilisation (IVF): Ovitrelle is administered to trigger final...
- Evidence level: L5
- Predicted indications (20):
- peptic esophagitis (98.4%)
- postural orthostatic tachycardia syndrome (98.3%)
- esophageal disease (97.6%)
- Raynaud disease (97.4%)
- non-syndromic esophageal malformation (96.9%)
- esophageal ulcer (96.8%)
- His bundle tachycardia (96.0%)
- sinoatrial block (95.9%)
- progressive familial heart block (95.7%)
- sinoatrial node disease (95.5%)
- restless legs syndrome (95.4%)
- esophageal atresia (disease) (95.3%)
- active peptic ulcer disease (95.3%)
- gastrojejunal ulcer (95.3%)
- peptic ulcer perforation (95.3%)
- migraine disorder (95.3%)
- esophageal leukoplakia (disease) (95.2%)
- acne (disease) (95.2%)
- dyskinesia of esophagus (95.2%)
- esophageal diverticulosis (95.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.